Figure 2
From: Blood-Brain Glucose Transfer in Alzheimer’s disease: Effect of GLP-1 Analog Treatment
Relationship between duration of AD and CMRglc (A), total cognitive score and CMRglc (B), duration of AD and Tmax, (C), total cognitive score and GUF (D), Tmax and CMRglc (E), and total cognitive score and net clearance of [18F]FDG. The points representing the averages of the healthy control group were not included in the analysis.
